Nexium (Esomeprazole Magnesium Trihydrate)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is employed to manage acid‑related disorders such as gastro‑oesophageal reflux disease and erosive oesophagitis in adult patients.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance, and reliable on‑time delivery to meet global healthcare needs across multiple continents.

Esomeprazole acts on the gastric proton pump pathway to reduce acid secretion in several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Erosive oesophagitis: facilitates ulcer healing and prevents recurrence. - NSAID‑induced gastric ulcer: protects the gastric mucosa and supports ulcer resolution. - Helicobacter pylori eradication (in combination therapy): enhances bacterial eradication rates when used with antibiotics.

Esomeprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may be self‑limiting. - Nausea: sensation of unease or urge to vomit. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): swelling, rash, difficulty breathing. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: signs of hepatic dysfunction. - Stevens‑Johnson syndrome: skin blistering and mucosal involvement. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

When prescribing or dispensing esomeprazole, consider the following precautions to ensure safe use.

- Assess renal function: adjust use in severe renal impairment. - Avoid concomitant use with known CYP2C19 inhibitors unless medically necessary. - Monitor for signs of infection: prolonged acid suppression may increase risk. - Use with caution in patients with osteoporosis: long‑term use may affect calcium absorption. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Esomeprazole can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - Methotrexate (high dose): increased toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: may increase serum levels. - Diazepam: may increase plasma concentration.